Switch View
© Globe Newswire
23.10.2025
ISIN: US21900C3088
CorMedix Inc
CRMD
LISTED
NASDAQ
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
News Preview
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that DefenCath has received an Innovative Technology designation from Vizient®, the largest healthcare perf...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US28531P1030
electroCore, Inc.
ECOR
LISTED
NASDAQ
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
News Preview
ROCKAWAY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the third quarter ended September 30, 2025, after the close of the market on Wednesday, November 5, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
News Preview
ZURICH, Oct. 23, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) (Nasdaq: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system ("CNS") disorders, and Kadimastem Ltd. (TASE: KDST) ("Kadimastem"), an advanced clinical-stage cell therapy compa...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
23.10.2025
ISIN: US9553061055
West Pharmaceutical Services Inc
WST
LISTED
NYSE
West Reports Third-Quarter 2025 Results
News Preview
- Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - - Achieved double-digit growth in HVP Components -- Strengthened executive leadership team, including recently appointed CFO Robert McMahon -- Increases Full-Year 2025 Revenue and EPS Guidance -...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
23.10.2025
ISIN: US45826H1095
Integer Holdings Corp
ITGR
LISTED
NYSE
Integer Holdings Corporation Reports Third Quarter 2025 Results
News Preview
~ Continued strong sales and profit growth in 3Q25 ~~ Updating 2025 sales and profit outlook; providing preliminary outlooks for 2026 and 2027 ~...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US19459J1043
Collegium Pharmaceutical Inc
COLL
LISTED
NASDAQ
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
STOUGHTON, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US22663K1079
Crinetics Pharmaceuticals Inc
CRNX
LISTED
NASDAQ
Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting
News Preview
Preliminary analysis of one-year progression-free survival data from Phase 2 study of novel SST2 agonist paltusotine under investigation for carcinoid syndrome demonstrated potential anti-tumor effects Preliminary analysis of one-year progression-free survival data from Phase 2 study of novel SST2 agonist paltusotine under investigation for carcino...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10ᵗʰ ESWI Influenza Conference 2025
News Preview
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it gave a late-breaking presentation on its non-vaccine influenza preventative candidate, CD388, at the European Scientific Worki...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US03837C1062
Apyx Medical Corp
APYX
LISTED
NASDAQ
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
News Preview
CLEARWATER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that financial results for the third quarter of fiscal year...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US6951271005
Pacira Biosciences Inc
PCRX
LISTED
NASDAQ
Pacira BioSciences to Present New Data from Three Real-World Studies with EXPAREL®
News Preview
-- Findings Presented at AMCP Nexus 2025 Annual Meeting -- BRISBANE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced real-world evidence evaluating the clinical effectiveness and econo...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US71722W1071
Phathom Pharmaceuticals Inc
PHAT
LISTED
NASDAQ
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting
News Preview
FLORHAM PARK, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced its participation in the American College of Gastroenterology’s (ACG) 2025 Annual Scientific Meeting, being h...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US09077B1044
Bioatla Inc
BCAB
LISTED
NASDAQ
BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society
News Preview
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced presentation of a poster entitled “Targeting HPV E6/E7 Upregulation of the Transmembrane...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
23.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces Secured Real Estate for Heal Wellness in Toronto's Eaton Center
News Preview
Toronto, Ontario--(Newsfile Corp. - October 23, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce the signing of a new franchise agreement and the securing of premium real estate for Heal Wellness ("Heal") in th...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US7743743004
Rockwell Medical Inc
RMTI
LISTED
NASDAQ
Rockwell Medical Named Fortune 'Best Workplaces in Manufacturing & Production' Second Year in a Row
News Preview
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Great Place to Work® and Fortune magazine selected Rockwell Medical for the 2025 Fortune Best Workplaces in Manufacturing...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each in Combination with Padcev® (enfortumab vedotin-ejfv), for Certain Patients with Muscle-Invasive Bladder Cancer
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for two supplemental Biologics License Applications (sBLA) for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each in combination with P...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SVRA
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Savara Inc. ("Savara " or "the Company") (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and E...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE: MOH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MOH
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina " or "the Company") (NYSE: MOH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. ("Baxter" or "the Company") (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 1...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics ("MoonLake" or "the Company") (NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics " or "the Company") (NASDAQ: CYTK ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: CA22717L1013
Cronos Group. Inc.
CRON
LISTED
TSX
Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025
News Preview
TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the invest...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US67577C1053
Ocugen Inc
OCGN
LISTED
NASDAQ
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
News Preview
MALVERN, Pa., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss the Company’s third quarter 2025 financial results and provide a business update at 8:3...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rul...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis to Report Third Quarter 2025 Financial Results on November 6
News Preview
REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results for the third quarter of 2025 on Thursday, November 6, 2025, following the close of market....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US47973J1025
Joint Corp
JYNT
LISTED
NASDAQ
The Joint Corp. to Host Conference Call on Thursday, November 6th to Discuss Third Quarter 2025 Results
News Preview
SCOTTSDALE, Ariz., Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work
News Preview
Redhook 81, a Cold One for Quittin’ Time Redhook 81, a Cold One for Quittin’ Time...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: CA2059531020
Conavi Medical Corp
CNVI
LISTED
TSX
Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025
News Preview
Company to Participate in Educational Imaging Sessions and Feature Hybrid IVUS/OCT Imaging Technology Company to Participate in Educational Imaging Sessions and Feature Hybrid IVUS/OCT Imaging Technology...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US45107K1025
iBio Inc
IBIO
LISTED
NASDAQ
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
News Preview
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference, taking place November 10–12, 2025 in Boston....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US09058V1035
BioCryst Pharmaceuticals Inc
BCRX
LISTED
NASDAQ
BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting
News Preview
RESEARCH TRIANGLE PARK, N.C., Oct. 23, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present four abstracts at the Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) taking place in Orlando, Fla., from November 6-10, 2025. The data will inclu...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics ("MoonLake " or "the Company") (NASDAQ: MLTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S....
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus " or "the Company") (NASDAQ: LNTH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Sec...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Savara Inc. ("Savara" or "the Company") (NASDAQ: SVRA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promul...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semler Scientific, Inc. ("Semler" or "the Company") (NASDAQ: SMLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SMLR
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Semler Scientific, Inc. ("Semler " or "the Company") (NASDAQ: SMLR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Secu...
Themefolio
Profiler
Peergroup
© Newsfile
23.10.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025
News Preview
Montreal, Quebec--(Newsfile Corp. - October 23, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce that it will present new scientific data highlighting the performance of its Accum® technolo...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD " or "the Company") (NASDAQ: LFMD ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ: LFMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promu...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US9174881089
Utah Medical Products Inc
UTMD
LISTED
NASDAQ
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
News Preview
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that were unusually hampered by global trade uncertainty.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) be...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: SE0011205202
Vitrolife AB
VITR
LISTED
STO
Vitrolife AB (publ) - Interim report Q3, 2025: Strong growth in Americas
News Preview
GOTHENBURG, Sweden, Oct. 23, 2025 /PRNewswire/ --
Third quarter
Sales of SEK 835 (867) million, 3% growth in local currencies and a 4% decrease in SEK, due to a significant currency impact of -7%. Organic growth in local curren...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US68621D1072
Organicell Regenerative Medicine, Inc.
OCEL
LISTED
OTC
ZEO ScientifiX(TM) Positioned for New Growth as Florida Opens Stem Cell Market
News Preview
New Florida stem cell law provides ZEO with new pathways to market and sell regenerative therapy products and advance clinical research initiatives FORT LAUDERDALE, FL / ACCESS Newswire / October 23, 2025 / ZEO ScientifiX™, Inc. (OTCQB:ZEOX) ("ZEO" or the "Company"), a clinical‑stage biopharmaceutical company focused on re...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US85859W1027
Stemtech Corporation
STEK
LISTED
OTC
Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP
News Preview
NAPLES, FL / ACCESS Newswire / October 23, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture in India with "INNOVENTURE DYNAMIC LLP". "STEMTECH HEALTHSCIENCES INDIA PRIVATE LIMITED" will be under the corporate stru...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US92919Y1029
VSee Health Inc
VSEE
LISTED
NASDAQ
VSee Health Strengthens Balance Sheet With The Elimination of Debt
News Preview
SAN JOSE, CALIFORNIA / ACCESS Newswire / October 23, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a pioneering force in telehealth innovation, recently announced record-setting revenue growth. However, the Company has also been able to eliminate over $5M in legacy SPAC debt as it continues to strengthen its balance sheet and position itself for long ter...
Themefolio
Profiler
Peergroup
© ActuNews
23.10.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
News Preview
Subscription and guarantee commitments totaling €5.9 million, representing 75.5% of the envisaged capital increase
Subscription price: €1.80 per share, representing a 29.4% discount to the closing price of the share on October 22, 2025
Subscription ratio: 6 new shares for 13 existing shares
Detachment of preferential subscr...
Themefolio
Profiler
Peergroup
© ActuNews
23.10.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma annonce le lancement d'une augmentation de capital avec maintien du DPS d'un montant d'environ 8M EUR
News Preview
Engagements de souscription et de garantie à hauteur de 5,9M€ représentant 75,5% de l'augmentation de capital envisagée
Prix de souscription : 1,80€ par action, soit une décote de 29,4% par rapport au cours de clôture de l'action le 22 octobre 2025
Parité de souscription : 6 actions no...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: DE000A11QVV0
Heidelberg Pharma AG
HPHA
LISTED
XETR
Heidelberg Pharma erhält Fast-Track-Status von der US FDA für seinen führenden ADC-Kandidaten HDP-101 zur Behandlung des multiplen Myeloms
News Preview
PRESSEMITTEILUNG
Heidelberg Pharma erhält Fast-Track-Status von der US FDA für seinen führenden ADC-Kandidaten HDP-101 zur Behandlung des multiplen Myeloms
FDA erkennt damit das Potenzial von HDP-101 zur Behandlung einer schweren oder lebensbedrohlichen Erkrankung mit hohem ungedecktem medizinischem Bedarf an
Ermöglicht häufigere Interaktionen m......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: DE000A11QVV0
Heidelberg Pharma AG
HPHA
LISTED
XETR
Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
News Preview
PRESS RELEASE
Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
Recognizes the potential of HDP-101 to address a serious or life-threatening condition with high unmet medical needs
Enables more frequent engagement with FDA and eligibility for rolling review to support ex......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo
News Preview
New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ACCESS Newswire / October 23, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical biotechn...
Themefolio
Profiler
Peergroup
© Newsfile
23.10.2025
ISIN: CH1176493729
Bachem Holding AG
BANB
LISTED
SIX
Bachem Announces Progress in Building K Start-Up and Expansion of Its Site in Vista, CA
News Preview
The capacity expansion in Bubendorf reached another important milestone with the inspection of Building K. The announced start-up is proceeding according to plan. In Vista, CA, Bachem acquired a property adjacent to its existing facility. The acquisition will enable a future capacity expansion at the Vista site, thereby strengtheni...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna to Host Investor Event - Analyst Day
News Preview
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations.A live webcas...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: CH1335392721
Galderma Group AG
GALD
LISTED
XWSX
Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance
News Preview
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first nine months of 2025, delivering record net sales along with strong commercial and innovation momentum across its portfolio.
Record net sales of 3.737 billion USD for the first nine months of the year, representing net sal...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Galenica bleibt auf Wachstumskurs
News Preview
MedienmitteilungAd hoc-Mitteilung gemäss Art. 53 KR
Der Umsatz der Galenica Gruppe ist bis zum dritten Quartal 2025 um 4.7% auf CHF 2'999.7 Mio. gewachsen.
Treiber für das Umsatzwachstum sind rezeptpflichtige Medikamente und Nahrungsergänzungsmittel.
Durch die Akquisition von Labor Team erwartet Galenica neu ein Umsatzwachstum zwischen 4% und 6% ......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Galenica remains on growth track
News Preview
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales grew 4.7% to CHF 2,999.7 million in the third quarter of 2025.
Sales growth is driven by prescription drugs and dietary supplements.
Thanks to the acquisition of Labor Team, Galenica now expects sales growth of between 4% and 6% and an increase in EBIT1 of between 10% an......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: IT0003828271
Recordati Industria Chimica e Farmaceutica SpA
REC
LISTED
EURONEXT
RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
News Preview
NEWS RELEASE...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: CH0013841017
Lonza Group AG
LONN
LISTED
SIX
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses
News Preview
Ad hoc announcement pursuant to Art. 53 LR
Strong CDMO1 performance in Q3 2025 in Integrated Biologics and Advanced Synthesis, while Specialized Modalities improved versus a soft H1
Large contract signings in Q3, including another significant commercial contract for Vacaville
Capsules & Health Ingredients (CHI) returned to growth as expected ......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: CA98980M1095
Zomedica Corporation
ZOM
LISTED
XASE
Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
News Preview
Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's leadership in targeted tPEMF innovation ANN ARBOR, MI / ACCESS Newswire / October 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"),...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Changes to the Roche Enlarged Corporate Executive Committee
News Preview
Basel, 23 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Nina Schwab-Hautzinger (1975) has been appointed Head of Group Communications and a member of the enlarged Corporate Executive Committee effective 1 February 2026....
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTORS: Kirby McInerney LLP Reminds Baxter International, Inc. Investors of Important Deadline in Class Action Lawsuit
News Preview
If you have suffered a loss on your Baxter International, Inc. (“Baxter” or the “Company”) (NYSE:BAX) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Investors have until...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
